-+ 0.00%
-+ 0.00%
-+ 0.00%

Mira Pharmaceuticals Launches Phase 1 Study of Oral Ketamir-2 for Chemotherapy-Induced Neuropathic Pain

Reuters·10/24/2025 11:30:24

Please log in to view news